Abstract
Ophthalmoscopic evaluation with either the direct or indirect ophthalmoscope has been the principal method of assessing the diabetic retina. Slip-lamp examination with a contact lens has proven highly valuable for studying more minute defects in the retinal structures. Photography of the retina, both regular and stereoscopic, has proven useful for carefully documenting retinal changes over long intervals of time.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Novotny H, Alvis DL. A method of photographing fluorescence in circulating blood in the human retina. Circulation 24: 82–86, 1961.
Brown JK, Jones AT. Retinopathy and diabetic control. Br J Ophthalmol, 48: 148–153, 1964.
Colwell JA. Effect of diabetic control on retinopathy. Diabetes 15: 497–499, 1966.
Hardin RC, Jackson RL, Johnston TL, Kelly HG. The development of diabetic retinopathy: effects of duration and control of diabetes. Diabetes 5: 397–405, 1956.
Jackson RL, Hardin RC, Walker GL, Hendricks AB, Kelly HG. Degenerative changes in young diabetic patients in relationship to level of control. Pediatrics 5: 959–971, 1950.
Keiding NR, Root HF, Marble A. Importance of control of diabetes in prevention of vascular complications. JAMA 150: 964–969, 1952.
Schlesinger FG, Franken S, van Lange LTP, Schwartz F. Incidence and progression of retinal and vascular lesions in long-term diabetes: a follow-up of a group of patients over 7 years. Acta Med. Scand 168: 483–488, 1960.
Spoont S, Dyer WW, Day R, Blazer H. Incidence of diabetic retinopathy relative to the degree of diabetic control. Am J Med Sci 221: 490–494, 1951.
Dolger H. Clinical evaluation of vascular damage in diabetes mellitus. JAMA 134: 1289–1291, 1947.
Larsson Y, Sterky G. Long-term prognosis in juvenile diabetes mellitus. Acta Paediatr 51 (Suppl 130): 1–76, 1962.
Oakley WG, Pyke DA, Tattersall RB, Watkins PJ. Long-term diabetes: a clinical study of 92 patients after 40 years. Q J Med 43: 145–156, 1974.
Taylor E., Adnitt PI. Factors relating to the progression of diabetic retinopathy. Am Heart J 82: 425–427, 1971.
Knowles HC. Long-term juvenile diabetes treated with unmeasured diet. Trans Assoc Am Physicians 84: 95–101, 1971.
Knowles HC, Guest GM, Lampe J, Kessler M, Skillman TG. The course of juvenile diabetes treated with unmeasured diet. Diabetes 14: 239–273, 1965.
Balodimos MC, Aiello LM, Gleason RE, Marble A. Retinopathy in mild diabetes of long duration. Arch Ophthalmol 81: 660–666, 1969.
White P. Childhood diabetes. Its course, and influence on the second and third generations. Diabetes 9: 345–355, 1960.
Caird FI, Garrett CJ. Progression and regression of diabetic retinopathy. Proc R Soc Med 55: 477–479, 1962.
Szabo AJ, Stewart AG, Joron GE. Factors associated with increased prevalence of diabetic retinopathy: a clinical survey. Can Med Assoc J 97: 286–292, 1967.
Parving HH, Noer I, Deckert T, Evrin PE, Nielson SL, Lyngsoe J, Mogensen CE, Rorth M, Svendsen PA, Trap-Jensen J, Lassen NA. The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 12:- 161–166, 1976.
Miki E, Fukuda M, Kuzuya T, Kosaka K, Nakao K. Relation of the course of retinopathy to control of diabetes, age, and therapeutic agents in diabetic Japanese patients. Diabetes 18: 773–780, 1969.
Pirart J. Diabete et complications degeneratives presentation d’une etude prospective portant sur 4400 cas observes entre 1947–1973. Diabete Metab 3: 97–107, 1977.
Job D, Eschwege E, Guyot-Argenton C, Aubry JP, Tchobroutsky G. Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes 25: 463–469, 1976.
Askikaga T, Borodic G, Sims EAH. Multiple daily insulin injections in the treatment of diabetic retinopathy. The Job study revisited. Diabetes 27: 592–596, 1978.
Constam GR. Zur spatprognose des diabetes mellitus. Helv Med Acta 32: 287–306, 1965.
Caird FI. Control of diabetes and diabetic retinopathy. In Symposium on the Treatment of Diabetic Retinopathy, Goldberg, MF, Fine, SL (eds.). PHS Pub. No. 1890. Health, Education and Welfare, 1968, Washington, DC: U.S. Department of 1968, pp. 107–114.
University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19 (Suppl. 2): 789–830, 1970.
University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19 (Suppl. 2): 789–830, 1970.
University Group Diabetes Program. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. JAMA 218: 1400–1410, 1971.
University Group Diabetes Program. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. JAMA 217: 77–784, 1971.
University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patience with adult-onset diabetes. Diabetes 25: 1129–1153, 1976.
Cahill GF, Etzwiler DD, Freinkel N. Diabetes 25 (editorial), 1976.
Shabo AL, Maxwell DS. Insulin-induced immunogenic retinopathy resembling the retinitis proliferans of diabetes. Trans Am Acad Ophthalmol Otolaryngol 81: 497–508, 1976.
Engerman RL. Animal models of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol 81: 710–715, 1976.
Engerman R, Bloodworth JMB, Nelson S. Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760–769, 1977.
British Multicentre Randomized Controlled Trial. Prolif erative diabetic retinopathy: treatment with xenon-arch photocoagulation. Brit Med J 1: 739–741, 1977.
The Diabetic Retinopathy Study Research Group. Preliminary report of the effects of photocoagulation therapy. Amer J Ophthalmol 81: 383–102, 1976.
L’Esperance FA Jr. Diabetic retinopathy. In: Symposium on Diabetes Mellitus. Medical Clinics of North America 62(4): 767–785, 1978.
Meyer-Schwickerath G. Light-Coagulation. St. Louis: C.V. Mosby Co., 1960.
L’Esperance FA Jr. An ophthalmic argon laser photocoagulation system: design, construction, and laboratory investigations. Trans Amer Ophthal Soc 66: 827–904, 1968.
L’Esperance FA Jr. Clinical photocoagulation with the krypton laser. Arch Ophthal 87: 693–700, 1972.
L’Esperance FA Jr. Clinical photocoagulation with the frequency-doubled neodymium yttrium-aluminum-garnet laser. Am J Ophthal 71: 631–638, 1971.
L’Esperance FA Jr. Ophthalmic lasers: photocoagulation, photoradiation and surgery. St. Louis: C.V. Mosby Co., 1983.
L’Esperance FA Jr., James WA Jr. Diabetic retinopathy: clinical evaluation and management. St. Louis: C.V. Mosby Co., 1981.
James WA Jr., L’Esperance FA Jr. Treatment of diabetic optic nerve neovascularization by extensive retinal photocoagulation. Am J Ophthalmol 78: 939–947, 1974.
L’Esperance FA Jr. Ocular photocoagulation. St. Louis: C.V. Mosby Co., 1975.
Little HP. In: Diabetic Retinopathy, Lynn JR, Snyder WB, Vaiser A (eds). New York: Grune and Stratton, 1974, pp. 133–144.
L’Esperance FA Jr. (ed). Current diagnosis and management of chorioretinal diseases. St. Louis: C.V. Mosby Co., 1977.
L’Esperance FA Jr, Freidman EA, Mondschein LG. Long term retention of vision following panretinal photocoagulation in diabetics. In: Diabetic Renal-Retinal Syndrome 2 Prevention and Management, L’Esperance FA Jr., Friedman EA (eds). New York: Grune and Stratton, 1982, pp. 285–300.
Diabetic Retinopathy Study Research Group. Preliminary report of the effects of photocoagulation therapy. Am J Ophthalmol 81: 383–402, 1976.
Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. Arch Ophthalmol 97: 654–655, 1979.
Davis MD. Discussion of presentation by Dr. George W. Blankenship. Ophthalmology 86(1):- 76–78, 1979.
Mandelcorn MS, Blankenship G, Machemer R. Pars plana vitrectomy for the management of severe diabetic retinopathy. Am J Ophthalmol 81: 561–570, 1976.
L’Esperance FA Jr. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A (ed). St. Louis: C.V. Mosby Co., 1977.
Okun E. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A. (ed). St. Louis: C.V. Mosby Co., 1977.
Douvas NG. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A. (ed). St. Louis: C.V. Mosby Co., 1977.
Kloti R. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A. (ed). St. Louis: C.V. Mosby Co., 1977.
Ryan SJ, Michels RG. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A (ed). St. Louis: C.V. Mosby Co., 1977.
Shea M, Young PW. In: New and Controversial Aspects of Vitreoretinal Surgery, McPherson A (ed). St. Louis: C.V. Mosby Co., 1977.
Machemer R. Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage. Ophthalmology 88 (7): 643–646, 1981.
Aaberg TM. Pars plana vitrectomy for diabetic traction retinal detachment. Ophthalmology 88 (7): 639–642, 1981.
L’Esperance FA Jr, et al. Long term retention of vision following vitrectomy in diabetics. In: Diabetic Renal-Retinal Syndrome 2 Prevention and Management, Friedman EA, L’Esperance E A Jr. (eds). New York: Grune and Stratton, 1982, pp. 277–283.
Luft R, Olivecrona H, Ikkos D, Kornerup I, Ljundgren H. Hypophysectomy in man—further experiences in severe diabetes mellitus. Br Med J 2: 752–756, 1955.
Poulsen JE. Recovery from retinopathy in a case of diabetes with Simmonds’ Disease. Diabetes 2: 7–12, 1953.
Bradley RF, Rees SB, Fager CA. Pituitary ablation in the treatment of diabetic retinopathy. Med Clin North Am 49: 1105–1124, 1965.
Kohner EM. Diabetic retinopathy: cause, treatment and prognosis. Unpublished M.D. thesis, University of London, 1969.
Kohner EM. In: Diabetic Retinopathy, Lynn JR, Snyder WB, Vaiser A (eds). New York: Grune and Stratton, 1974, pp. 205–214.
Kohner E, Hamilton A, Joplin G, Fraser TR. Florid diabetic retinopathy and its response to treatment by photocoagulation. Diabetes 25: 104–110, 1976.
Marble A. Late complications of diabetes. A continuing challenge. Diabetologia 12: 193–199, 1976.
Kohner EM. A controlled trial of pituitary ablation. In: Diabetic Retinopathy, Lynn JR, Snyder WB, Vaiser A (eds). New York: Grune and Stratton, 1974, pp. 205–214.
Kohner E, Hamilton A, Joplin G, et al. Florid diabetic retinopathy and its response to treatment by photocoagulation or pituitary ablation. Diabetes 25: 104–110, 1976.
Bloodworth JMB, Engerman RL. Diabetic microangiopathy in the experimentally diabetic dog and its prevention by careful control with insulin. Diabetes 22 (suppl. 1): 290, 1973.
Didier Jr, Eschwege E, Guyot-Argenton C, et al. Effect of multiple daily injections on the course of diabetic retinopathy. Diabetes 25: 463–469, 1976.
Cahill CF Jr, Etzwiler DD, Freinkel N. Blood glucose control in diabetes. Diabetes 25: 237–239, 1976.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
L’esperance, F.A. (1986). Clinical Evaluation and Management of Diabetic Retinopathy. In: Friedman, E.A., Peterson, C.M. (eds) Diabetic Nephropathy. Developments in Nephrology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2287-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2287-0_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9410-8
Online ISBN: 978-1-4613-2287-0
eBook Packages: Springer Book Archive